A pilot study to evaluate clinical efficacy and safety of autologous serum therapy in patients with atopic dermatitis

Ajou University Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1. Current standard medical therapies more than 2 months and moderate-to-severe atopic dermatitis)
•2. =10% lesion body surface area (BSA) of atopic dermatitis involvement in area

•Exclusion criteria
•1) Patients under the age of 13 year.
•2) Patients who are unable to agree on their own (emergency patients, patients with mental disability, patients with limited capacity to consent due to stroke or delirium caused by diabetes).
•3) Patients with severe disease whose expected survival duration is less than 3 months.
•4) Pregnancy or planned pregnancy within 1 year
•5) Skin condition not appropriate for blood sampling and transfusion
•6) Presence of skin comorbidities that may interfere with study assessments

发起方

Ajou University Hospital